From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome
CRP (mean mg/l)
change (%)
Initial
8 Weeks
8 Weeks - Initial
Formula B (↑dose)
11.58 ± 1.11
8.17 ± 0.61b*
-29.45‡
Formula A (↓dose)
10.99 ± 1.26
9.33 ± 0.43a
-15.10‡
Placebo
12.46 ± 1.30
12.05 ± 1.39
-3.31